🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study was to see if adding a new type of medication rec...
Status
Completed
Location
Genova Clinical Research
Start Date
2013-07-10
Trial ID
NCT01908829
To evaluate the safety and plasma concentration change of YM178 after singl...
Status
Completed
Location
Multiple Locations
Start Date
2012-05
Trial ID
NCT01720212
Treatments Being Tested
A study that evaluates the interaction in healthy subjects of the heart dru...
Status
Completed
Location
SGS Aster
Start Date
2008-09
Trial ID
NCT01663961
Treatments Being Tested
The purpose of the study is to investigate how quickly and to what extent Y...
Status
Completed
Location
Pharma Bio-Research B.V.
Start Date
2005-01
Trial ID
NCT01646294
Treatments Being Tested
The purpose of this study is to assess the pharmacokinetics of three doses ...
Status
Completed
Location
Multiple Locations
Start Date
2009-04-30
Trial ID
NCT00940121
Treatments Being Tested
The study aimed to compare age and gender differences for increasing doses ...
Status
Completed
Location
Kendle Nederland
Start Date
2005-05
Trial ID
NCT01478503
Treatments Being Tested
A study to evaluate how much of the active compound of mirabegron comes int...
Status
Completed
Location
Pharma Bio Research
Start Date
2006-02
Trial ID
NCT01478529
Treatments Being Tested
The purpose of this study is to assess the pharmacokinetic interaction of m...
Status
Completed
Location
MDS Pharma Services (US) Inc.
Start Date
2006-07
Trial ID
NCT01476800
Treatments Being Tested
The purpose of this study is to evaluate the pharmacokinetics as well as th...
Status
Completed
Location
Site BE32009 Univ.Ziekenhuis Antwerpen
Start Date
2014-09-21
Trial ID
NCT02211846
Treatments Being Tested
The purpose of this study was to assess tolerability of mirabegron compared...
Status
Completed
Location
Site US10002 Urology Centers of Alabama
Start Date
2014-07-24
Trial ID
NCT02138747
Treatments Being Tested